A review of the relevant literature and the National Institute of Health clinical trial registry did not yield evidence that such a study has been published or is currently underway
June 21st, 2024: Mass tort lawsuit in Philadelphia challenges 15 million Americans' GLP-1 drug safety A mass tort lawsuit is currently underway in a federal court in Philadelphia, addressing serious concerns regarding the safety and regulatory oversight of widely used weight-loss medications including Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro
Nadkarni P, Chepurny OG, and Holz GG
The company discontinued its 3-milliliter vials of Humalog, which is mainly used by hospitals, to free up capacity for the 10-milliliter vials, according to the company's response letter to lawmakers
All of us produce GLP-1, which is an incretin hormone that gets released into our bloodstream when we eat
R., & Schmidt, H